Page 2

Daily Deal Round Up: April 13, 2021
SafeGuard Cyber has raised $45m in a Cisco-backed debt and equity round while Pine Labs has paid the same amount to buy portfolio company Fave.
Brii brightens up with IPO plans
The infectious disease drug developer has applied to float in Hong Kong, which will enable the WuXi AppTec-backed 6 Dimensions Capital to exit.
Tend drills into $125m series C
The personalised dental care provider increased its overall funding to almost $200m in a GV-backed series C round.
StoneWise stocks up with $100m
The drug discovery platform developer will support its growth with new funding from investors including SIG and Legend Capital.
Vaccitech shoots for US IPO
Alphabet, Tencent and Gilead Sciences are in line to achieve exits, after the vaccine developer filed to go public on the Nasdaq Global Market.
Artiva activates $100m IPO plans
The NK cancer drug provider has filed to go public in an offering which would enable GC and its GC Labcell subsidiary to exit.
Hologic hoists in Mobidiag
Autobio Diagnostics is set to exit the molecular diagnostic test provider through a purchase by women’s health-focused technology provider Hologic.
Carta Healthcare carves out series A funding
Mass General Brigham’s AI Digital Innovation Fund has chipped into a $17.3m round for the healthcare data technology provider.
Analysis: Ikena goes public
The oncology drug developer, backed by Bristol Myers Squibb, secured close to $144m in its IPO. This is an exit from a space that has seen much corporate support over the past decade.
Corporate venturing deal net: 5-9 April 2021
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

test reg